JPMorgan Chase & Co’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-15,085
| Closed | -$73K | – | 5139 |
|
|
2020
Q1 | $73K | Buy |
15,085
+97
| +0.6% | +$469 | ﹤0.01% | 4035 |
|
|
2019
Q4 | $159K | Buy |
14,988
+294
| +2% | +$3.12K | ﹤0.01% | 3891 |
|
|
2019
Q3 | $153K | Buy |
14,694
+3,690
| +34% | +$38.4K | ﹤0.01% | 3848 |
|
|
2019
Q2 | $166K | Buy |
11,004
+1,715
| +18% | +$25.9K | ﹤0.01% | 3833 |
|
|
2019
Q1 | $119K | Buy |
9,289
+2,067
| +29% | +$26.5K | ﹤0.01% | 3951 |
|
|
2018
Q4 | $69K | Buy |
7,222
+673
| +10% | +$6.43K | ﹤0.01% | 4170 |
|
|
2018
Q3 | $109K | Buy |
6,549
+937
| +17% | +$15.6K | ﹤0.01% | 4085 |
|
|
2018
Q2 | $90K | Buy |
5,612
+264
| +5% | +$4.23K | ﹤0.01% | 4118 |
|
|
2018
Q1 | $82K | Sell |
5,348
-46,995
| -90% | -$721K | ﹤0.01% | 3998 |
|
|
2017
Q4 | $817K | Buy |
52,343
+51,550
| +6,501% | +$805K | ﹤0.01% | 3145 |
|
|
2017
Q3 | $9K | Buy |
+793
| New | +$9K | ﹤0.01% | 4073 |
|
|
2017
Q1 | – | Sell |
-25,121
| Closed | -$269K | – | 4605 |
|
|
2016
Q4 | $269K | Buy |
25,121
+22,632
| +909% | +$242K | ﹤0.01% | 3539 |
|
|
2016
Q3 | $27K | Sell |
2,489
-1,211
| -33% | -$13.1K | ﹤0.01% | 3700 |
|
|
2016
Q2 | $25K | Buy |
+3,700
| New | +$25K | ﹤0.01% | 3673 |
|
|
2013
Q4 | – | Sell |
-142,837
| Closed | -$6.47M | – | 3843 |
|
|
2013
Q3 | $6.47M | Sell |
142,837
-61,308
| -30% | -$2.78M | ﹤0.01% | 1891 |
|
|
2013
Q2 | $4.87M | Buy |
+204,145
| New | +$4.87M | ﹤0.01% | 1967 |
|